Key facts
- This page summarizes Ares Trading S.A.'s Form 4 filing for PRECIGEN, INC. (PGEN).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 14 Oct 2021, 18:02.
Ares Trading S.A. - 12 Oct 2021 Form 4 Insider Report for PRECIGEN, INC. (PGEN)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- PGEN
- Reported as of
- 12 Oct 2021
- Net transaction value
- -$666,756
- SEC form
- 4
- Accepted by SEC
- 14 Oct 2021, 18:02:06 UTC
- Prior SEC filing
- 12 Oct 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Cedric Hyde, Authorized Signatory of Merck Serono SA
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Ares Trading S.A. filed Form 4 for PRECIGEN, INC. (PGEN) on 14 Oct 2021.
Change
- Previous filing in this sequence was filed on 12 Oct 2021.
- Current net transaction value: -$666,756.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PGEN
transaction
Common Stock
Sale
- Transaction value
- $299,474
- Shares
- -63,900
- Change %
- -0.31%
- Price
- $4.69
- Shares after
- 20,727,048
- Date
- 12 Oct 2021
- Ownership
- Direct
- Footnotes
- F1
PGEN
transaction
Common Stock
Sale
- Transaction value
- $367,282
- Shares
- -79,896
- Change %
- -0.39%
- Price
- $4.60
- Shares after
- 20,647,152
- Date
- 13 Oct 2021
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Ares Trading S.A. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 1 footnote
Footnote F1
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ares Trading, S.A. on April 29, 2021.The plan was terminated effective October 13, 2021.